Protalix Biotherapeutics Stock Price on August 14, 2024
| PLX Stock | USD 1.68 0.03 1.75% |
Below is the normalized historical share price chart for Protalix Biotherapeutics extending back to April 09, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protalix Biotherapeutics stands at 1.68, as last reported on the 27th of November, with the highest price reaching 1.73 and the lowest price hitting 1.65 during the day.
If you're considering investing in Protalix Stock, it is important to understand the factors that can impact its price. Protalix Biotherapeutics is dangerous given 3 months investment horizon. Protalix Biotherapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.23, which implies the firm had a 0.23% return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.06% are justified by taking the suggested risk. Use Protalix Biotherapeutics Semi Deviation of 2.38, risk adjusted performance of 0.1779, and Coefficient Of Variation of 450.74 to evaluate company specific risk that cannot be diversified away.
At this time, Protalix Biotherapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Total Stockholder Equity is likely to rise to about 35.2 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 51 M in 2024. . Price Earnings Ratio is likely to rise to 15.18 in 2024, whereas Price To Sales Ratio is likely to drop 1.74 in 2024. Protalix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of May 1998 | 200 Day MA 1.1866 | 50 Day MA 1.1888 | Beta 0.672 |
Protalix |
Sharpe Ratio = 0.2295
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PLX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.63 actual daily | 41 59% of assets are more volatile |
Expected Return
| 1.06 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
| 0.23 actual daily | 18 82% of assets perform better |
Based on monthly moving average Protalix Biotherapeutics is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protalix Biotherapeutics by adding it to a well-diversified portfolio.
Price Book 3.8818 | Enterprise Value Ebitda 5.6271 | Price Sales 3.2508 | Shares Float 54.7 M | Wall Street Target Price 14 |
Protalix Biotherapeutics Main Headline on 14th of August 2024
PLX Stock Earnings Protalix BioTherapeutics Misses EPS, Beat... by investorplace.com
PLX stock results show that Protalix BioTherapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Protalix Biotherapeutics Valuation on August 14, 2024
It is possible to determine the worth of Protalix Biotherapeutics on a given historical date. On August 14, 2024 Protalix was worth 1.04 at the beginning of the trading date compared to the closed value of 0.93. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Protalix Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Protalix Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Protalix Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Protalix Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.05 | 1.07 | 1.04 | 1.04 | 206,949 | |
08/14/2024 | 1.04 | 1.04 | 0.82 | 0.93 | 624,890 |
| 0.93 | 0.99 | 0.93 | 0.95 | 253,055 |
| Backtest Protalix Biotherapeutics | | | Protalix Biotherapeutics History | | | Protalix Biotherapeutics Valuation | Previous | Next |
Protalix Biotherapeutics Trading Date Momentum on August 14, 2024
| On August 15 2024 Protalix Biotherapeutics was traded for 0.95 at the closing time. Highest Protalix Biotherapeutics's price during the trading hours was 0.99 and the lowest price during the day was 0.93 . The net volume was 253.1 K. The overall trading history on the 15th of August 2024 contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 2.15% . The trading delta at closing time to current price is 4.30% . |
Protalix Biotherapeutics Fundamentals Correlations and Trends
By evaluating Protalix Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Protalix Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Protalix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Protalix Biotherapeutics Stock history
Protalix Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protalix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protalix Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protalix Biotherapeutics stock prices may prove useful in developing a viable investing in Protalix Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 82.4 M | 86.5 M | |
| Net Loss | -13.4 M | -14.1 M |
Protalix Biotherapeutics Stock Technical Analysis
Protalix Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Protalix Biotherapeutics Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Protalix Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Protalix Biotherapeutics November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Protalix Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protalix Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Protalix Biotherapeutics stock market strength indicators, traders can identify Protalix Biotherapeutics entry and exit signals to maximize returns
Protalix Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protalix Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Protalix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protalix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1779 | |||
| Jensen Alpha | 1.1 | |||
| Total Risk Alpha | 0.2843 | |||
| Sortino Ratio | 0.2731 | |||
| Treynor Ratio | (1.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.